DABIGEN 75
DABIGEN 75 contains Dabigatran Etexilate 75 mg, an oral anticoagulant used to prevent blood clot formation. It works by directly inhibiting thrombin, thereby reducing the risk of stroke and systemic embolism, especially in patients with atrial fibrillation. It is also used in the prevention and treatment of conditions like DVT and pulmonary embolism. Regular use ensures effective and safe blood thinning under medical supervision.
Related products
METOMED AM 50
METOMED AM 50 is a combination therapy used for effective management of hypertension and related...
TELLME 40 CT
TELLME 40 CT contains Telmisartan 40 mg + Chlorthalidone 12.5 mg. Telmisartan helps relax and...
TELLME MT 25
TELLME MT 25 is a combination of Telmisartan 40 mg + Metoprolol 25 mg. Telmisartan...
TELLME TRIO CC
TELLME CC combines Telmisartan 40 mg + Cilnidipine 10 mg + Chlorthalidone 12.5 mg. This...
TELLME 40 CT 6.25
TELLME 40 CT 6.25 includes Telmisartan 40 mg + Cilnidipine 10 mg + Chlorthalidone 6.25...
TELLME 80 CL
TELLME 80 CL contains Telmisartan 80 mg + Cilnidipine 10 mg, designed for patients needing...
TELLME AMH
Composition : Telmisartan 40 mg + Amlodipine 5 mg + Hydrochlorothiazide 12.5 mg.
